Clinical Trial Update: Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates a combination of imatinib, capecitabine, and cisplatin in patients with unresectable or metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Gleevec (Imatinib)
• Platinol (cisplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Technical University of Munich | Conditions: Gastric Cancer | Phase 1 | Status: COMPLETED